Trial Profile
Integrated Overactive Bladder Clinical Trial in clinical practice III.
Status:
Not yet recruiting
Phase of Trial:
Phase III
Latest Information Update: 06 Oct 2011
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Overactive bladder
- Focus Therapeutic Use
- Acronyms INTACT III
- 06 Oct 2011 New trial record